Legal Policy to Handle Medicine Price in Indonesia: A Comparison Study With Other Countries
Abstract
The use of medicinal right with an affordable price becomes a necessity for the public. The affordable medicine will reduce public health risks due to the public inability to buying common generic medication. An irrational difference in the medicine selling price at the consumer level was caused by a free price determined by pharmacy industries in the market mechanism. The medicine selling price policies for pharmacies were only accommodated through the Minister of Health Decree Number 720/Menkes/SKIX/2006 which in fact can not provide a solution. Therefore, the government has to control the selling price in the market mechanism and to seek the strong legal force.
Authors who publish with us agree to the following terms:
- Authors retain copyright and grant the publisher right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this proceeding.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the proceeding's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this proceeding.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories, pre-prints sites or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater dissemination of published work